Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
Programmable Paracrine-Mimetic Microneedle System for Temporal Regulation of Cardiac Repair.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Dai Yichen, Du Pengchong, Wang Zhaoyang, Surilige, Fokta Rangga, Tan Renjian, Zhao Xiqing, Zhang Shuoyi, Wang Yuecheng, Zhang Yixin, Fu Ziliang, Gong Rui, Jiang Cheng, He Yisheng, Wang Qiguang, Li Renke, Lim Khoon, Tang Junnan, Cui Xiaolin
Аннотация
Dynamic paracrine signaling governs tissue repair, yet replicating this temporal complexity using acellular systems remains challenging. While recent advances include microcapped microneedle patches and the TIMED platform, these systems face limitations in customizability, release duration, and fabrication simplicity. Here, this study reports a programmable microneedle platform that mimics the temporal paracrine signaling logic of stem cell therapy by generating phase-biased, kinetically staggered, and partially overlapping availability of TGF-β, IGF-1, and VEGF through a tris(2,2'-bipyridyl)dichlororuthenium(II) hexahydrate/sodium persulfate (Ru/SPS)-modulated tyramine crosslinked hydrogel network. This system demonstrates enhanced advantages, including straightforward tunability of release kinetics via Ru/SPS concentration adjustment, extended release duration up to ∼60 days, and a simplified fabrication process. In myocardial infarction models, this stem cell-inspired temporal release promoted anti-inflammatory, anti-apoptotic, and pro-angiogenic responses, restoring ventricular function. Direct schedule-control experiments further showed that the tested TGF-β/IGF-1/VEGF program outperformed 7- and 28- day simultaneous-window delivery and two order-swapped 7/14/28-day programs across functional, structural, angiogenic, and cardiomyocyte-proliferation readouts. This strategy establishes a generalizable framework for engineering time-coded therapeutic materials that emulate biological signaling programs.